Randomized Comparison of Sirolimus and Paclitaxel Drug-Eluting Stents for Long Lesions in the Left Anterior Descending Artery. An Intravascular Ultrasound Study

Journal of the American College of Cardiology

Volumn 49, Issue 5, 2007, Pages 539-546

  Petronio, Anna Sonia ^a   De Carlo, Marco ^a   Branchitta, Giulia ^a   Papini, Barbara ^a   Ciabatti, Nicola ^a   Gistri, Roberto ^a   Cortese, Bernardo ^a   Gherarducci, Gherardo ^a   Barsotti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GLYCERYL TRINITRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PACLITAXEL; RAPAMYCIN; SIMVASTATIN;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; DRUG IMPLANTATION; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; STENTS; TUBULIN MODULATORS; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33846601311     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.09.042     Document Type: Article

References (29)

1. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
3. Colombo A., Drzewiecki J., Banning A., et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
4. Sousa J.E., Costa M.A., Abizaid A.C., et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 104 (2001) 2007-2011
5. Sousa J.E., Costa M.A., Sousa A.G., et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 107 (2003) 381-383
6. Sousa J.E., Costa M.A., Abizaid A., et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation 111 (2005) 2326-2329
7. Serruys P.W., Degertekin M., Tanabe K., et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 106 (2002) 798-803
8. Degertekin M., Regar E., Tanabe K., et al. Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound. Am J Cardiol 91 (2003) 1046-1050
9. Tanabe K., Serruys P.W., Degertekin M., et al. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial. Circulation 109 (2004) 196-200
10. Weissman N.J., Koglin J., Cox D.A., et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1201-1205
11. Mintz G.S., Nissen S.E., Anderson W.D., et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37 (2001) 1478-1492
12. Cheneau E., Pichard A.D., Satler L.F., Suddath W.O., Weissman N.J., and Waksman R. Intravascular ultrasound stent area of sirolimus-eluting stents and its impact on late outcome. Am J Cardiol 95 (2005) 1240-1242
13. Mintz G.S., Shah V.M., and Weissman N.J. Regional remodeling as the cause of late stent malapposition. Circulation 107 (2003) 2660-2663
14. Lemos P.A., Hoye A., Goedhart D., et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 109 (2004) 1366-1370
15. Petronio A.S., Amoroso G., Limbruno U., et al. Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound. Am Heart J 149 (2005) 520-526
16. Aoki J., Colombo A., Dudek D., et al. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 112 (2005) 3876-3883
17. Stone G.W. Outcomes of the polymer-based, paclitaxel-eluting TAXUS stent in complex lesions: principal clinical and angiographic results from the TAXUS-V pivotal randomized trial. Presented at: Scientific Sessions of the American College of Cardiology (2005) March 6-9, Orlando, FL.
18. Hoffmann R., Guagliumi G., Musumeci G., et al. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials. Catheter Cardiovasc Interv 66 (2005) 499-506
19. de Lezo J.S., Medina A., Pan M., et al. Drug-eluting stent for complex lesions: latest angiographic data from the randomized rapamycin versus paclitaxel CORPAL study. (abstr). J Am Coll Cardiol 45 Suppl A (2005) 75A-76A
20. Mintz G.S., Hong M.K., Raizner A.E., et al. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents. Am J Cardiol 95 (2005) 107-109
21. Kaneda H., Koizumi T., Ako J., et al. Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation. Am J Cardiol 96 (2005) 1237-1241
22. Hong M.K., Mintz G.S., Lee C.W., et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113 (2006) 414-419
23. Aoki J., Abizaid A.C., Serruys P.W., et al. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 46 (2005) 1670-1676
24. Windecker S., Remondino A., Eberli F.R., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
25. Dibra A., Kastrati A., Mehilli J., et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
26. Morice M.C., Colombo A., Meier B., et al. Sirolimus- vs. paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904
27. Sawhney N., Moses J.W., Leon M.B., et al. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation 110 (2004) 374-379
28. Dangas G., Ellis S.G., Shlofmitz R., et al. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. J Am Coll Cardiol 45 (2005) 1186-1192
29. Kastrati A., Dibra A., Eberle S., et al. Sirolimus-eluting stents vs. paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 294 (2005) 819-825